Results 161 to 170 of about 180,168 (218)

Protective Human Papillomavirus Type 16/18 Vaccine-Induced Neutralizing Antibody Levels Remain Elusive. [PDF]

Open Forum Infect Dis
Lehtinen M, Eriksson T, Petäjä T, Harjula K, Heikkilä K, Hokkanen M, Butt J, Michels B, Sehr P, Müller M, Pimenoff V, Waterboer T.   +11 more
europepmc   +1 more source

Evaluation of candidate reference materials for the harmonization of Lassa fever serology. [PDF]

Emerg Microbes Infect
Bentley EM, Ithete N, Mitchell J, Richardson SAS, Bernasconi V, Killip M, Garry RF, Branco L, Günther S, Atkinson E, Rigsby P, Hinrichs M, Oestereich L, Thielebein A, Omoifo V, Omiunu R, Esumeh R, Okogbenin S, Kristiansen PA, Page M, Ogbaini-Emovon E, Mattiuzzo G, Collaborative Study Participants.   +22 more
europepmc   +1 more source

Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential. [PDF]

PLoS Pathog
Korber B, Seaman MS, Mkhize NN, Greene K, Gao H, Shen X, Domin E, Tang H, Theiler J, Wagh K, Moore PL, Williamson C, Mullins JI, Doria-Rose NA, Montefiori D, Giorgi EE.   +15 more
europepmc   +1 more source

Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. [PDF]

J Virol
Singh S, Kumar S, Luthra K.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Broadly Neutralizing Antiviral Antibodies

Annual Review of Immunology, 2013
A fascinating aspect of viral evolution relates to the ability of viruses to escape the adaptive immune response. The widely held view has been that the great variability of viral glycoproteins would be an absolute obstacle to the development of antibody-based therapies or vaccines that could confer broad and long-lasting protection.
Corti D., Lanzavecchia A.
openaire   +3 more sources

Production of Neutralizing Antibody

2018
Techniques employing monoclonal antibodies (mAbs) are widely used in the initial development phase of biologics. The usefulness of mAbs in basic RA research has been established based on their characteristics, including specificity of binding, homogeneity, and ability to be produced on a large scale.
Erika, Takemasa, Shuang, Liu, Hitoshi, Hasegawa   +2 more
openaire   +2 more sources

Neutralization of HIV by Antibodies

2008
Antibodies can neutralize HIV-1 with potency and cross-reactivity that varies widely and is related but not correlated to their antigen-binding affinity. Therefore, in addition to measuring binding affinity, an evaluation of the antibody neutralizing activity in tissue cultures is important for development of antibody-based therapeutics, design of ...
Ilia, Prado, Timothy R, Fouts, Antony S, Dimitrov   +2 more
openaire   +2 more sources

The secretion of virus-neutralizing antibodies

Archiv f�r die gesamte Virusforschung, 1967
Considerable evidence supports the concept that the immune defense against infectious agents that attack primarily the cells of the mucosal linings lies in secreted antibodies belonging to the IgA class of immunoglobulins. The problem that thus arises, in connection with the possible use of adjuvants in active immunization against these infectious ...
A, Giovanardi, A, Albano, L, Amante, S, De Donato, B, Pernis   +4 more
openaire   +2 more sources